Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 09:51AM ET
1.71
Dollar change
-0.04
Percentage change
-2.57
%
IndexRUT P/E- EPS (ttm)-1.32 Insider Own25.33% Shs Outstand116.36M Perf Week-82.22%
Market Cap198.38M Forward P/E- EPS next Y-0.61 Insider Trans-14.81% Shs Float86.88M Perf Month-81.24%
Income-96.51M PEG- EPS next Q-0.20 Inst Own86.86% Short Float15.61% Perf Quarter-70.09%
Sales10.66M P/S18.61 EPS this Y1.41% Inst Trans16.28% Short Ratio3.28 Perf Half Y-59.60%
Book/sh0.05 P/B33.67 EPS next Y56.22% ROA-189.48% Short Interest13.56M Perf Year-29.55%
Cash/sh0.85 P/C2.01 EPS next 5Y- ROE- 52W Range1.68 - 10.62 Perf YTD-49.10%
Dividend Est.- P/FCF- EPS past 5Y-8.72% ROI-1270.08% 52W High-83.95% Beta1.73
Dividend TTM- Quick Ratio1.06 Sales past 5Y0.00% Gross Margin95.68% 52W Low1.49% ATR (14)1.03
Dividend Ex-Date- Current Ratio1.06 EPS Y/Y TTM59.67% Oper. Margin-586.31% RSI (14)18.57 Volatility17.39% 9.38%
Employees25 Debt/Eq0.33 Sales Y/Y TTM- Profit Margin-905.38% Recom1.83 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.29 EPS Q/Q-26.99% Payout- Rel Volume4.61 Prev Close1.75
Sales Surprise- EPS Surprise-203.80% Sales Q/Q- EarningsNov 07 BMO Avg Volume4.13M Price1.71
SMA20-79.41% SMA50-79.83% SMA200-72.36% Trades Volume1,926,000 Change-2.57%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Downgrade UBS Buy → Neutral $13 → $2
Nov-29-24Downgrade RBC Capital Mkts Outperform → Sector Perform $12 → $4
Jul-31-24Initiated William Blair Outperform
Mar-26-24Initiated RBC Capital Mkts Outperform $12
Feb-22-24Initiated Leerink Partners Outperform $12
Jan-04-22Downgrade Barclays Overweight → Equal Weight $44 → $7
Aug-27-21Downgrade Goldman Neutral → Sell $16 → $10
Jun-25-21Resumed Goldman Neutral $18
Oct-08-20Initiated Truist Buy $85
Apr-22-20Initiated Goldman Buy $60
Nov-30-24 06:40AM
05:30AM
Nov-29-24 03:56PM
10:49AM
10:48AM
10:06AM Loading…
10:06AM
08:46AM
Nov-28-24 07:02AM
Nov-27-24 04:10PM
Nov-07-24 07:00AM
Nov-05-24 07:00AM
Oct-29-24 12:00PM
09:40AM
Oct-10-24 09:40AM
Sep-24-24 09:40AM
12:00PM Loading…
Sep-23-24 12:00PM
Sep-18-24 10:56AM
10:52AM
07:00AM
Sep-04-24 07:00AM
Aug-07-24 07:00AM
Jul-31-24 02:37PM
Jul-01-24 07:00AM
Jun-29-24 08:50PM
May-10-24 02:47PM
May-09-24 01:55PM
07:00AM
May-07-24 07:00AM
Apr-15-24 07:00AM
Apr-04-24 07:00AM
05:12PM Loading…
Mar-28-24 05:12PM
04:42PM
04:30PM
Mar-13-24 09:23AM
Mar-08-24 04:32AM
Mar-06-24 07:00AM
Feb-28-24 01:01PM
09:48AM
08:05AM
08:00AM
Feb-21-24 09:21AM
Feb-15-24 07:00AM
Jan-05-24 09:23AM
03:31AM
02:32AM
Jan-04-24 04:05PM
Jan-03-24 07:00AM
Nov-09-23 08:34AM
07:30AM
Nov-02-23 07:00AM
Nov-01-23 07:00AM
Oct-20-23 01:22PM
Sep-28-23 07:00AM
Sep-06-23 07:00AM
Aug-11-23 07:42AM
Aug-10-23 07:00AM
Jul-29-23 11:07AM
Jul-25-23 07:00AM
Jun-22-23 07:00AM
Jun-15-23 07:00AM
May-25-23 07:00AM
May-11-23 07:00AM
May-05-23 02:24PM
Apr-24-23 07:00AM
07:00AM
Mar-23-23 06:30AM
Mar-18-23 09:54AM
Mar-01-23 07:00AM
Feb-16-23 10:46AM
07:00AM
Feb-09-23 07:00AM
Jan-04-23 06:00AM
Nov-09-22 07:00AM
Oct-31-22 07:00AM
Oct-25-22 07:00AM
Oct-09-22 09:13AM
Oct-06-22 11:18AM
07:00AM
Sep-02-22 09:55AM
Aug-12-22 07:00AM
Jul-28-22 07:00AM
Jun-22-22 10:12PM
04:10PM
Jun-16-22 08:08AM
Jun-03-22 07:00AM
May-20-22 09:50AM
May-19-22 07:00AM
May-18-22 11:47AM
11:03AM
May-17-22 11:31AM
May-13-22 10:30AM
08:28AM
May-12-22 06:59AM
May-11-22 07:32AM
May-05-22 07:30AM
May-03-22 10:47AM
May-02-22 07:12AM
Apr-28-22 10:24AM
Apr-12-22 11:47AM
Apr-08-22 11:39AM
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Funtleyder Leslie D.Chief Financial OfficerAug 22 '24Sale5.8313,53078,880277,911Aug 23 04:35 PM
Perfetti RiccardoChief Medical OfficerAug 22 '24Sale5.8322,681132,230986,853Aug 23 04:33 PM
Shendelman ShoshanaPresident and CEOAug 13 '24Sale6.18357,4232,208,8744,810,430Aug 14 07:01 PM
Shendelman ShoshanaPresident and CEOAug 12 '24Sale5.98300,0001,794,0005,167,853Aug 14 07:01 PM
Shendelman ShoshanaPresident and CEOAug 14 '24Sale5.93119,591709,1754,690,839Aug 14 07:01 PM
Shendelman ShoshanaOfficerAug 12 '24Proposed Sale6.211,000,0006,210,000Aug 09 08:43 PM
Shendelman ShoshanaPresident and CEOJun 06 '24Sale4.3261,795266,9543,756,019Jun 10 04:29 PM
Perfetti RiccardoChief Medical OfficerJun 06 '24Sale4.3222,00395,0531,009,534Jun 10 04:28 PM
Funtleyder Leslie D.Chief Financial OfficerJun 06 '24Sale4.3216,98073,354291,441Jun 10 04:25 PM
ALEXANDRIA REAL ESTATE EQUITIE10% OwnerJun 05 '24Sale4.24150,000636,0005,855,077Jun 06 06:45 PM
ALEXANDRIA REAL ESTATE EQUITIE10% OwnerJun 04 '24Sale4.21150,000631,5006,005,077Jun 06 06:45 PM
Shendelman ShoshanaPresident and CEOMar 14 '24Sale5.39318,5731,717,1083,817,814Mar 18 06:12 PM
Perfetti RiccardoChief Medical OfficerMar 14 '24Sale5.39110,804597,2341,031,537Mar 18 06:02 PM
Hansard AdamChief Commercial OfficerMar 14 '24Sale5.3948,871263,415732,919Mar 18 06:00 PM
Funtleyder Leslie D.Chief Financial OfficerMar 14 '24Sale5.3928,727154,839308,421Mar 18 05:57 PM